Industry Segment: Pharmaceutical & Biotech | Word Count: 685 Words

GALWAY, IRELAND--August 5, 2019--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--Pfizer (NYSE:PFE) (New York, New York) and Mylan (NASDAQ:MYL) (Canonsburg, Pennsylvania) are to merge their off-patent drugs businesses into a new company that will have estimated revenues of $19 billion to $20 billion to become the world's largest generic drugmaker.

Within this article: Details merger, value of new company, leading products, markets